OFFICIAL PUBLICATION OF

by its subsidiary APPco

MSD melanoma drug listed

Megan Haggan 20/04/2015

melanoma: dermatologist examines mole on woman's shoulder

A new treatment for advanced melanoma which has seen significant media attention is now available in Australia. MSD announced that its anti-PD1 immunotherapy KEYTRUDA (pembrolizumab) has been registered by the TGA for the treatment of the most deadly form of skin cancer – advanced melanoma. The treatment has been the subject of a Change.org petition

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Medics to ‘fight’ Doctor of Pharmacy title

For a century in Australia, Doctors also had a double bachelor and no PhD

William Stevenson

No products available

In a busy pharmacy you could easily spend an hour a day talking to patietns about shortages, following up with…

Ben Wishaw

No products available

60DD doesn’t help with the shortage like Duodart

Paul Lai

Doctor of Pharmacy addresses anomaly

I thought it was from 1 Jan, not 1 July.

taron p

MSD melanoma drug listed

Previous Council urges Aussies to consider bowel cancer

Next TGA upgrades eBusiness website

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Council urges Aussies to consider bowel cancer

Next TGA upgrades eBusiness website

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.